Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. (Q53249720)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 November 2014

Language	Label	Description	Also known as
English	Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.	scientific article published on 26 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

immune cell infiltration

1 reference

based on heuristic

inferred from title

author name string

Jin Won Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Kyung Han Nam

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Sang-Hoon Ahn

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Do Joong Park

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Hyung-Ho Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Se Hyun Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Hyun Chang

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Jeong-Ok Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Yu Jung Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Hye Seung Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Jee Hyun Kim

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Soo-Mee Bang

12

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Jong Seok Lee

13

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Keun-Wook Lee

14

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

publication date

26 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

19

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

42-52

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Surveillance against tumors--is it mainly immunological?

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

PD-L1 expression is increased in a subset of basal type breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Overall survival and PD-L1 expression in metastasized malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

A new member of the immunoglobulin superfamily--CTLA-4

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0440-5

21 January 2018

CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25424150

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-014-0440-5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/25424150

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53249720&oldid=2212046430"